Who is the CEO of VSTM? | Glauxie AI

Q: Who is the CEO of VSTM?

Verastem, Inc. (VSTM) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Daniel W. Paterson. Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual... Employees: 102.

Q: What does VSTM company do?

Learn what VSTM does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling VSTM?

Track recent insider buys and sells for VSTM with transaction details, amounts, and trends.

Q: What sector is VSTM in?

Find VSTM sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of VSTM?

🦉

Verastem, Inc. (VSTM)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODaniel W. Paterson

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase...

Key Executives

Name	Title
Cathy Carew	Chief Organizational Effectiveness Officer
Colleen Mockbee	Global Head of Regulatory Affairs & Development
Daniel Calkins	Chief Financial Officer
Daniel W. Paterson	President, Chief Executive Officer & Director
John Hayslip	Chief Medical Officer
Jonathan Pachter	Chief Scientific Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

VSTM Profile Financials

What does VSTM company do? Are insiders buying or selling VSTM? What sector is VSTM in?